Dr Erin Schenk, Assistant Professor, Thoracic Oncology, University of Colorado describes the results of the ADAURA trial and the implications for her practice.

Read more here - [ Ссылка ]

Register on our website for news straight to your inbox - [ Ссылка ]

Watch the full series on YouTube - [ Ссылка ]
Or our website - [ Ссылка ]

___

Keep up to date with us across our network:

Email us at - info@medicalimi.com
Site - [ Ссылка ]
Twitter - [ Ссылка ]
Instagram - [ Ссылка ]
Facebook - [ Ссылка ]
LinkedIn - [ Ссылка ]

This content is for informational purposes only, and does not replace the advice of your own doctor or healthcare professional. Copyright © 2021 MedicalUpdateOnline.

IMI (a trading name of ICR UK Limited) is a digital communications agency that specialises in the pharmaceutical and medical industries.

IMI was founded in 2003 by the current CEO Peter Mas-Mollinedo, a pharmacist and forward-thinking entrepreneur. IMI’s primary activities include the production of medical educational journals and bulletins, medical conference coverage and video interviewing of health care professionals worldwide to disseminate information such as trial results, new products, research, drug approvals, new accreditations, etc.

It is a trusted provider of medical information to its extensive database of medical health care professionals in the UK, Europe and beyond.

To find out more about IMI, please see our websites www.medicalupdateonline.com and www.medicalimi.com. Alternatively, you can email us at info@medicalimi.com.

свернуть